September 30th 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
August 18th 2024
To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.
August 17th 2024
Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.
June 24th 2024
The can’t-miss event on July 13 features speakers and CE sessions focused on streamlining pharmacy finances and services.
April 1st 2024
The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.
New pharmacist organization seeks end to deterioration of profession
Pharmacy Alliance launches in Galveston, Texas, to promote better working conditions for pharmacists.
Chronic hepatitis C treatment complicated by kidney disease
New guidelines discuss how to treat HCV patients who also have kidney disease.
Pancreatic cancer therapies emerge
New approaches for treating pancreatic cancer include immunotherapy, biological agents, hyperthermia, and botanicals.
New, easier-to-swallow capsule approved to treat bipolar disorder
FDA has approved Stavzor, delayed-release soft gelatin capsules of valproic acid, for the treatment of bipolar disorder.
Pediatric stroke guidelines stress differences from adult treatment
The American Heart Association issues new recommendations for treatment of pediatric stroke.
State Medicaid cuts force pharmacists to take drastic measures
Cuts in state Medicaid payments for product reimbursements and dispensing fees are forcing pharmacists to cut services and turn away Medicaid patients.
Safe disposal of meds tested in Wisconsin pilot program
Two counties in Wisconsin are using a reverse-distributor to round up unwanted drugs. The program, called Get the Meds Out, helps consumers in Waukesha and Winnebago Counties make free returns.
Government-mandated inhaler switch goes into effect January 1, 2009
Pharmacists need to get ready now to help patients make the government-mandated switch from toxic CFC-driven MDIs to environmentally friendly HFA inhalers.
Pharmitas and University of Washington collaborate on MTM program
Pharmitas and U. of Washington will work together to create a medication therapy management program.
Anti-HIV drug now indicated to treat chronic hepatitis B
Chronic hepatitis B can now be treated with a new drug.
CVS to buy Longs Drugs
CVS Caremark acquires Longs Drugs, a California-based chain of 521 stores, for $2.9 billion.
Walgreens challenging SF tobacco ban
The ban, the first of its kind in the nation, is set to take effect Oct. 1.
Florastor gains shelf space at Duane Reade
The products will be stocked in the retail chain's digestive section.
TNF-blocker drug manufacturers must strengthen warnings
Mandate comes in regard to the risk of invasive fungal infections.
FDA speeds up review of kidney cancer therapy
Drug may become the first approved once-daily therapy to treat advanced kidney cancer.
Kansas City pharmacist sentenced in fraud case
The government claimed that Doug Albers and his wholesale business, Albers Medical Distributors, grossed $26.3 million in fake or stolen drugs.
Pharmacists say some PhRMA revisions were needed
Thirty-one percent of pharmacists surveyed said PhRMA's new marketing code is long overdue.
Medco and FDA to collaborate on pharmacogenomics
The groups have signed a two-year agreement.
Criminals targeting online pharmacies
Online pharmacy sales during the past year tripled to $12 billion.
FDA speeds up review of Droxidopa
The drug is marketed in Japan to treat low blood pressure.
Consumers fighting North Dakota pharmacy ownership law
The law means North Dakota consumers must travel elsewhere to buy the more than 300 drugs retailers like Wal-Mart and Target offer for $4.
Pharmacy customers want self-service
The Wilson Rx Pharmacy Satisfaction Survey Report indicates pharmacy customers see convenience, price, and overall pharmacy services as key to customer satisfaction.
Diabetes drug under scrutiny by FDA
FDA scrutinizes Byetta, a diabetes drug from Eli Lilly and Amylin, following reports of deaths.
Women's health group seeks FDA help in clarifying labels for pregnant or breast-feeding women
Goal is to identify potential health risks for these groups of women.
Concordia receives first campaign gift toward pharmacy school
Shopko, a discount retailer, donated $1 million.
California pharmacists endorse halt of Medi-Cal cuts
California was directed by the Federal District Court in Los Angeles to stop the 10 percent cuts in Medi-Cal reimbursement payments to healthcare providers.
Patients in low-income areas more sensitive to co-payment changes
The study investigated whether individuals in low-income areas are more strongly influenced by rising prescription drug co-payments than individuals in higher income areas.
Medco, FDA forge research partnership
The collaboration will study genetic testing and the impact of genetics on the efficacy of prescription drugs.
Prescription drug ads: Where's the beef?
This year's prescription drug ads are not really impacting consumers.
Colorado chain launches safe drug disposal program
Consumers can take their unused or unwanted drugs back to their pharmacies.